Claim Missing Document
Check
Articles

Found 2 Documents
Search

Polycystic Ovary Syndrome: Pathophysiology, Risk Factors, and Clinical Management – A Literature Review Luluk Hermawati; I Made Arya Subadiyasa; Nur Bebi Ulfah Irawati; Hilizza Awalina Zulfa; Nur Ayu Virginia Irawati; Rossa Amelia
JURNAL KEDOKTERAN RAFLESIA Vol 12 No 1 (2026): Juni
Publisher : UNIVERSITAS BENGKULU

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33369/juke.v12i1.48386

Abstract

Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder commonly observed in women of reproductive age and is associated with reproductive, metabolic, and psychological disturbances. This article aims to comprehensively review the pathophysiology, risk factors, and clinical management of PCOS based on current scientific evidence. The method employed was a narrative literature review, conducted through a systematic search of scientific articles in PubMed, Scopus, Google Scholar, and ScienceDirect databases. The keywords used included polycystic ovary syndrome, PCOS pathophysiology, insulin resistance, anti-Müllerian hormone, and clinical management. Publications in English and Indonesian from 2015 to 2025 were included. The selected articles comprised original research studies, systematic reviews, and relevant literature reviews. The findings indicate that the pathophysiology of PCOS is multifactorial, involving hormonal alterations, insulin resistance, hyperandrogenism, and dysfunction of the hypothalamic–pituitary–ovarian axis, which leads to chronic anovulation. The main risk factors for PCOS include obesity, insulin resistance, sedentary lifestyle, unbalanced nutritional status, as well as metabolic and genetic predispositions, all of which contribute to the heterogeneous clinical manifestations of the syndrome. The management of PCOS is individualized and multidisciplinary, with lifestyle modification as the first-line therapy, supported by dietary interventions, physical activity, and pharmacological treatment according to clinical indications. This review highlights the importance of an integrated approach in the management of PCOS to improve clinical outcomes and prevent long-term complications.
CRYPTOSPORIDIOSIS: EPIDEMIOLOGI, PATOGENESIS, MANIFESTASI KLINIS, DIAGNOSIS, DAN PENATALAKSANAAN: TINJAUAN LITERATUR Nur Bebi Ulfah Irawati; Luluk Hermawati; Silvia Fitrina Nasution; Putri Damayanti; Yuda Nabella Prameswari; Hilizza Awalina Zulfa
JURNAL BIOSENSE Vol 9 No 2 (2026): Edisi April 2026
Publisher : Universitas PGRI Banyuwangi, Jalan Ikan Tongkol No 01, Telp (0333) 421593, 428592 Banyuwangi 68416

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36526/biosense.v9i2.7673

Abstract

Cryptosporidiosis is a parasitic infection caused by protozoa of the Cryptosporidium genus that infect humans and animals worldwide. The disease remains a significant public health concern, particularly in regions with limited access to clean water and adequate sanitation. This study aimed to review recent scientific evidence regarding the epidemiology, pathogenesis, clinical manifestations, diagnosis, and management of cryptosporidiosis. A literature review method was employed by analyzing scientific articles published between 2015 and 2025 retrieved from databases including PubMed, Scopus and Google Scholar. Relevant studies were selected based on predefined inclusion criteria and analyzed narratively. The review indicates that Cryptosporidium hominis and Cryptosporidium parvum are the most common species causing human infection and account for the majority of cases worldwide. Transmission primarily occurs through the fecal–oral route via contaminated water or food, as well as direct contact with infected hosts. Infection involves parasite attachment and invasion of intestinal epithelial cells, leading to mucosal damage, malabsorption, and diarrhea. Clinical manifestations vary depending on the host's immune status, ranging from mild self-limiting diarrhea in immunocompetent individuals to severe and chronic infection in immunocompromised patients. Diagnosis is commonly established through microscopic detection of oocysts, antigen-based assays, and molecular methods such as polymerase chain reaction (PCR). Current management mainly focuses on supportive therapy, while nitazoxanide remains the only antiparasitic drug approved by the FDA for the treatment of cryptosporidiosis. Therefore, improvements in sanitation, development of diagnostic methods, and effective prevention strategies are essential to reduce the global burden of cryptosporidiosis.